Eris Lifesciences Ltd Completes Equity Share Allotment Under ESOP-2017 Scheme
Eris Lifesciences Limited has successfully completed an allotment of equity shares following the exercise of options under its ESOP-2017 Scheme. The transaction, finalized on July 30, 2026, resulted in a change in the company's paid-up share capital.The allotment involved 4,816 equity shares at a premium of Rs. 450.04 per share. This issuance is part of the ongoing execution of the ESOP-2017 Scheme by the company.
The completion of this allotment updates the company's financial structure, resulting in an increase in paid-up share capital from the previous standing amount.
Key figures regarding the change in paid-up capital are detailed below:
| Capital Metric | Before Allotment (Equity Shares) | After Allotment (Equity Shares) |
|---|---|---|
| Paid Up Share Capital | Rs. 13,85,78,489 | Rs. 13,85,83,305 |
| Number of Equity Shares | 13,85,78,489 (Re. 1/- each) | 13,85,83,305 (Re. 1/- each) |
The paid-up share capital of Eris Lifesciences Ltd has consequently increased from Rs. 13,85,78,489 to Rs. 13,85,83,305 following the allotment on July 30, 2026.
ERIS Stock Price Movement
As of 3:10 PM, Eris Lifesciences Limited shares slip by 3.51% during live trading, with the stock currently sitting at ₹1376.50. Trading remains robust as the equity processes a volume of 200,037 shares in the active session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.